Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
165-301: A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety and Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN165 Self Administered by Adults with Phenylketonuria Not.......
Burton, Barbara K
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
6/17/13
→
6/15/15
Funding
BioMarin Pharmaceutical Inc.
(165-301)
View all
View less